RL
Robert-jan Lamers
Company Director
Immundnz
I'm working on
2 months ago
Immune safety assessment and risk prediction for biologics and advanced therapeutics, including cytokine release, immunogenicity and translational immunology.
I'm looking for
2 months ago
Collaborations with pharmaceutical, biotech and academic partners developing biologics, immunotherapies, cell therapies and gene therapies who need support with immune safety assessment, cytokine release risk evaluation and immunogenicity analysis.
About
Immundnz is an immunology-focused technology company dedicated to improving the safety and success of advanced therapeutics. We combine expertise in cytokine biology, immunogenicity, immune safety and predictive modeling to help developers identify and mitigate immune-related risks early in development. Our goal is to enable safer biologics, immunotherapies, cell therapies and gene therapies through better prediction and understanding of immune responses.
RL
Robert-jan Lamers
Company Director
Immundnz
Work experience
Company Director
Top industry applications
Not enough data yet.
Results may appear later and can be imperfect.
Expertise
AgingBiochemistryBioinformaticsBiological ComplexityBiopharmaceuticsBiotechnology
Last updated Jul 2026
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.